Clinical Trial Update: Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing extended venous thromboembolism prophylaxis with rivaroxaban versus aspirin after total hip and knee arthroplasty has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Aspirin (Aspirin)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: David Anderson | Conditions: Venous Thromboembolism | Phase 3 | Status: COMPLETED